Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Women with PCOS often have more sleep problems than the general population.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Most diabetic patients have skin problems, which are more common with longer diabetes duration and poor blood sugar control.

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Resistance training improved BMI and menstrual regularity more in women with PCOS than aerobic training.

Caffeic acid helps protect rats from the harmful effects of acrylamide.

Hyperprolactinemia should be treated before confirming a PCOS diagnosis.

A woman with PCOS successfully overcame secondary infertility and became pregnant with triplets after treatment.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

People with early psychosis eat more calories, saturated fat, and sugar, and the drug olanzapine may lead to eating even more calories.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Women with newly diagnosed PCOS may have worse gum health than those treated for PCOS.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.